Phenotypic and Molecular Characterization of Candida Species in Urine Samples from Renal Failure Patients
Science Journal of Clinical Medicine
Volume 2, Issue 1, January 2013, Pages: 14-25
Received: Dec. 25, 2012; Published: 10, 2013
Views 3188      Downloads 171
Authors
Mohammed S. Alhussaini, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Saudi Arabia
Noha F. El-Tahtawi, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Al-Dawadmi, Shaqra University, Saudi Arabia
AhmadM. Moharram, Department of Botany and Microbiology, Faculty of Science,Assuit University,Egypt
Article Tools
PDF
Follow on us
Abstract
The prevalence of Candida infections of the urinary tract (candiduria)has increased significantly over the past few years due to various predisposing factors especially in hospitalized patients. The predisposing factors frequently asso-ciated with candiduria are urinary tract instrumentation, prior antibiotic use, prolonged hospital stay, extremes of age, di-abetes mellitus, female sex and use of immunosuppressive therapy. The purpose of this study was to apply different diag-nostic techniques for characterization of Candida species in urine samples from renal failure patients using urinary cathe-ters. Results showed that 20 % of renal failure patients were suffering from candiduria. Females were more affected than males (64% versus 36% of culture positive cases). Diabetes mellitus and catheterization were the obvious risk factors. Dif-ferent Candida isolates showed variations in their phenotypic (macroscopic and microscopic) characteristics when cultured on CHROMagar Candida, corn meal agar and bovine serum. Candida albicans was the most common species being isolated from 54% of positive cases. C.krusei (Teleomorph: Pichia kudriavzevii), C. glabrata and C.tropicalis were respectively identified in 24%, 16% and 6% of samples. Positive germ tube test (in serum) and production of chlamydospores (on corn meal agar) were only confined to C. albicans. Sequencing of rRNA gene (18S covering ITS1 and ITS2) confirmed the identification of the four Candida species. In vitro antifungal sensitivity test (disc diffusion method) revealed that all Candida strains were inhibited by Amphotericin-B and Nystatin. Other compounds as Clotrimazole, Itraconazole, Ketoconazole, Tioconazole, Fluconazole and Sertaconazole were effective against 50% - 67% of Candida strains. All isolates of C. glabrata were resistant to Clotrimazole and Sertaconazole.It is highly recommended to follow standard hygienic precautions to avoid cross contamination by Candida during hemodialysis. Complications following candiduria can be avoided by early diagnosis and proper treatment with effective antifungal agents.
Keywords
Candiduria, Renal Failure Patients, Chromagar Candida, RNA Gene Sequencing
To cite this article
Mohammed S. Alhussaini, Noha F. El-Tahtawi, AhmadM. Moharram, Phenotypic and Molecular Characterization of Candida Species in Urine Samples from Renal Failure Patients, Science Journal of Clinical Medicine. Vol. 2, No. 1, 2013, pp. 14-25. doi: 10.11648/j.sjcm.20130201.13
References
[1]
Álvarez-Lerma, F.; Nolla-Sallas, J.; Palomar, M.; Jordá, R.; Carrasco, N. and Bobillo, F.( 2003): Candiduria in critically ill patients Admitted to intensive care medical units. Inten Care Med 29:1069-1076.
[2]
Ang B. S. P., A. Telenti, B. King, J. M. Steckelberg and W. R. Wilson (1993): "Candidemia from a urinary tract source: microbiological aspects and clinical significance", Clin. Infect. Dis., 17, 662-666.
[3]
Ayeni, O. Riederer, KM. Wilson, FM. and Khatib, R.(1999): Clinicians' reaction to positive urine culture for Candida or-ganisms. Mycoses,42:285-9.
[4]
Badawi H., A. I. Kamel, N. Fam, M. El-Said and S. Elian (2004): "Candida urinary infections: emerging species, anti-fungal Susceptibility trends and antibody response", Egypt J.Med. Microbiol., 13 (1), 1-14.
[5]
Bakir, M., N. C. Cerikciog˘lu, A. Tirtir, S. Berrak, E. O¨ zek, and C. Canpolat.2003. Pichia anomala fungaemia in immu-nocompromised children. Mycoses47:231–235.
[6]
Banerjee. SN.; Emori, TG.; Culver, DH.; Gayness, PP. ;Jarvis, WR.; Hovan, T. Edwards, JR.; Tolson, J.; Her-derson, T. and Martone, WJ. (1991): Secular trends in noso-comial primary bloodstream infections in he United States, 1980 - 1989.
[7]
National nosocomial Infections surveillance system. Am J Med 91-3B,86S-89S.
[8]
Behiry, I. K.; El Hedeki, S. KH. and Mah-fouz,M.(2010):Candida infection associated with urinary ca-theter in critically ILL patients. Identification, antifungal susceptibility and risk factors. Research Journal of Medicine and Medical Science,5(1):79-86.
[9]
Berrouane, Y. F., Herwaldt, L. A. & Pfaller, M. A. (1999). Trends inantifungal use and epidemiology of nosocomial yeast infections ina university hospital. J Clin Microbiol 37, 531-537.
[10]
Bhavan, PS.; Rajkumar, R.; Radhakrishnan, S.; Seenivasan, C. and Kannan, S. (2010): Culture and Identification of Candida albicans from Vaginal Ulcer and Separation of Eno-lase on SDS-PAGE. Interna J Biol; 2:84-93.
[11]
Bukhary, Z. A.(2008): Candiduria: A review of clinical sig-nificance andmanagement. Saudi J Kidney Dis Transpl. 19:350-60.
[12]
Campbell, C.K.; Holmes, A.D.; Davey, K.G.; Szekely, A.; Warnock,D.W. (1998): Comparison of a new chromogenic agar with the germ tube method for presumptive identification of Candida albicans. Eur J Clin Microbiol Infec Dis 17: 367-8.
[13]
Coleman, D. C.; Bennett, D. E.; Gallagher,P. J.; Flint, S. R.; Nolan, A.;Mulcahy, F. M.; Sullivan, D. J.;Henman, M. C.; Russell, R. J. And Shanley, D. B. (1995): Oral candidiasis and HIV infection: anti-fungal drug resistance and changes in Candida population dynamics. In: Greenspan JS,Greenspan D, Greenspan JS, Greenspan D (eds) Oral manifestations of HIVinfection. Quintessence publishing Company, Chicago, IL.
[14]
Coleman, D. C.; Bennett, D. E.; Sullivan,D. J.; Gallagher, P. J.;Henman, M. C.; Shanley, D. B. and Russell,R. J. (1993): Oral Candida in HIV infection and AIDS: new perspec-tives/new approaches. Crit.Rev. Microbiol., 19:61–82.
[15]
Conceição, G.C.; Coelho, P.P.; Sousa Junior, M.A.; Pereira, M.L.;Miguel, D.S.C.G.; Toralles, M.B.P. (2005): Avaliação do teste tubo germinativo em secreção vaginal a fresco para triagem de Candida albicans: um teste rápido. Newslab 73: 106-12.
[16]
Ellis D, Davis S, Alexiou H, Handke R, and Bartley R. (2007): Descriptions of medical fungi. 2nd edition. Nexus Print Solutions, Australia. p. 20-40.
[17]
Ellis, D. (2011 a): Antifungal susceptibility testing. (Neo-Sensitab and E-test methods. Notes on disc diffusion and E-test methods). Mycology Online. The University of Adelaide CRICOS Provider No. 00123M.
[18]
Ellis, D. (2011b): Antifungal susceptibility profile (Australian antifungal susceptibility data for Candida isolates from recurrent volvovaginal candidiasis (2007-2009) using the CLSI M44-A2 disc susceptibility standard for yeasts). My-cology Online. The University of Adelaide. CRICO Provider N. 00123M.
[19]
Febré, N.; Silva, V.; Medeiros, EAS.; Wey, SB.; Colombo, AL.and Fischman, O. (1999): Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catherization. J Clin Microbiol 37: 1584-1586.
[20]
Fisher, F.; Cook, N. (1998): Reagents, stains, media and methods. In:Fisher, F. & Cook, N. (eds) Fundamentals of di-agnostic mycology.Saunders, 320-340.
[21]
Gatica, J.L.M.; Goic, I.B.; Martinez, M.A.T. et al. (2002): Utilidad del agar cromocandida para el diagnostico diferencial de Candida spp aisladas de muestras vaginales. Rev Chil Obstet Ginecol 67: 300-304.
[22]
Girgis, S. A., El-Mehalawy, A. A. and Rady, L. M. (2009 Comparison between culture and non-culture based methods for detection of Nosocomial fungal infections of Candida spp.in intensive care unit patients. Egypt. Acad. J. biolog. Sci. 1: 37-47.
[23]
Godoy, P.; Almeida, L.P.; Colombo, A.L. (2001): Identifica-ción de Candida albicans utilizando el medio cromogénico Albicans ID. Rev Iberoam Micol 18: 197-199.
[24]
Guler,S.,Ural,O.,Findik,D.andArslan,U.(2006):Risk factors of nosocomial candiduria. Saudi Med J.; Vol 27 (11): 1706- 1710.
[25]
Jain N., Kohli R., Cook E., Gialanella P., Chang T.,(2007): Biofilm Formation by and Antifungal Susceptibility of Can-dida Isolates from Urine Applied and Environmental Micro-biology, 73: 1697–1703.
[26]
Javris, WR.; Edwards, JR. and Culver, DH.et al. (1999): Nosocomialinfection rates in adult and pediatric intensive care units in the United States.National Nosocomial Infections Surveillance System.Amer J Med, 91:185S-9S.
[27]
Kangogo, M.C.; Wanyoike,M.W.; Revathi,G. and Bii, C.C. (2011):Phenotypic characterization of Candida albicans from clinical sources in Nairobi, Kenya. Afr.J.Health Sci.19:19-23.
[28]
Kauffman C. A., J. A. Vazquez, J. D. Sobel,H. A. Gallis, D. S. McKinsey, A. W.Karchmer, A. M. Sugar, P. K. Sharkey, G. J. Wise, R. Mangi, A. Mosher, J. Y. Lee, and W. E. Dis-mukes (2000): "Prospective multicenter surveillance study of funguria in hospitalized patients", ibid., 30, 14-18.
[29]
Kauffman, CA.(2005); Candiduria. Clin Infect Dis.41: 371-376.
[30]
Kauffman, CA.; Vazquez, JA.; Sobel, JD.; Gallis, HA.; McKinsey, DS. and Karchmer, AW. et al . (2000): Prospec-tive multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis. 30:14-8.
[31]
Khlif,M.; Sellami,H.; Sellami, A. ; Makni, F.; Cheikhrouhhou, F.; Chelly, H.; Bouaziz, M.and Ayadi,A.(2007): Detection and identification of Candida sp. By PCR in candidemia diagnosis.J.deMycologie Medicale, 17:256-260.
[32]
Klotz, S., and R. Smith. 1990. Candida albicans adherence to subendothelial extracellular matrix components is inhibited by arginine-glycine-aspartic acid peptides. Clin. Res. 38:13A.
[33]
Kobayashi, CC.; de Fernandes, OF.; Miranda, KC.; de Sousa, ED.and Silva, Mdo. R.(2004): Candiduria in hospital patients: A study prospective. Mycopathologia;158: 49-52.
[34]
Koehler, A. P., Chu, K. C., Houang, E. T. & Cheng, A. F. (1999). Simple, reliable and cost effective yeast identification scheme for the clinical laboratory. J Clin Microbiol 37, 422–426.
[35]
Kronvall,G. And Karlsson, I.(2001): Fluconazole and Vori-conazole Multidisk Testing of Candida Species for Disk Test Calibration and MIC Estimation.J.Clin.Microbiol. 39: 1422- 1428.
[36]
Lacaz, C.S.; Porto, E.; Martins, J.E.C. et al. (2002): Levedu-ras deinteresse médico. In: Lacaz, C.S., Porto, E., Martins, J.E.C, Vaccari-Heins, E.M., De Melo, N.T. (eds) Tratado de MicologiaMédica. SãoPaulo: Sarvier, 123-73.
[37]
Lundstrom T and Sobel J.( 2001): Nosocomial candiduria: A review. Clin Infect Dis. 32:1602-1607.
[38]
Milan, E.P.; Zaror, L. (2004): Leveduras: identificação labo-ratorial. In:Sidrim, J.J.C. & Rocha, M.F.G. (eds) Micologia Médica à luz de Autores contemporâneos. Rio de Janeiro: Guanabara Koogan, 89-101.
[39]
Nawrat, U; Grzybek-Hryncewicz, K and Karpiewska, A. (2000): Susceptibilty of Candida species to antimycotics de-termined by microdilution method. Mikol. Lek. 7: 19-26.
[40]
Orovcova E., J. Lacka, L. Drgona, M.Studena, L. Sevcikova and S. Spanik (1996):"Funguria in cancer patients: analysis of risk factors, clinical presentation and outcome in 50 pa-tients", Infection, 24, 319- 323.
[41]
Otag, F. et al. (2005): An outbreak of Pichia ohmeri infection in the paediatric intensive care unit: case reports and review of the Literature.Mycoses 48, 265-269.
[42]
PakshirK., M. Moghadami, M. Emami and P. Kord Ba-cheh(2004): "Prevalence and identification of etiological agents of funguria in Foley catheterized patients", J.Med. Res. Shiraz. Univ. Med. Sci. 3, 33-41.
[43]
Passos, XS.; Sales, WS.; Maciel, PJ.; Costa, CR.; Miranda, KC. andLemos, Jde. A.(2005): Candida colonization in in-tensivecare unit patients' urine. Mem Inst Oswaldo Cruz;100: 925-928.
[44]
Pfaller, M.A.;S.A. Messer, R.J. Hollis, R.N. Jones, G.V.Doern, M.E.Brandt and R. A. Hajjeh (1991):Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.Diagn. Microbiol. Infect. Dis. 33:217-222.
[45]
Pfaller, MA.; Houston, A.and Coffmann S. (1996): Applica-tion of CHROMagarCandida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol; 34:58-61.
[46]
Platt, R.; Polk, BF.; Murdock, B. and Rosner, B.(1986):Risk factors for nosocomial urinary tract infection. Amer J Epi-demiol, 124:977- 985.
[47]
Rashwan,N.M.Mohamed,AK.A. Saif El-Deen,S. Ahmed,E.H. and Imail,S.A.(2010): Pattern of Candida uri-nary tract infections among cancer patients in south Egypt Cancer Institute. Bull. Pharm. Sci., Assiut University, 33:121-130.
[48]
Schaberg,D.R., D.H.Culver and R.P.Gaynes (1991):Major trends in the microbial etiology of nosncomial etiology of nosocomial infections .AM.J.Med.91:72S-75S.
[49]
Schonebeck,J. and Ansehn, S. (1972): The occurrence of yeast-like fungi in the urine under normal conditions and in various types of urinary pathology. Scand J Urol Nephrol. 6:123-8.
[50]
Shay, AC. and Miller, LG.(2004):An estimate of the inci-dence ofCandidutia among hospitalized patients in the United States. Infect Control Hosp Epi-demiol , 25:894-5.
[51]
Sobel, JD. and Vasquez, JA. (1999): Fungal infections of the urinarytract. World J Urol 17, 410-414.
[52]
Sobel JD, Kauffman CA, Mckinsey D, et al.(2000) Candidu-ria: A randomized, double-blind study of treatment with flu-conazole and placebo. Clin Infect Dis. 30(1):19-24.
[53]
Sobel, J. D. (2007): Vulvovaginal candidosis. Lancet, 369:1961–1971.
[54]
Storfer S P, Medoff G, Fraser VJ, Powderly WG and Duna-gan WC (1994): Candiduria: retrospective review in hospi-talized patients Infect Dis Clin Pract. 3:23-29.
[55]
Sulivan, DJ.; Westerneng, TJ.; Haynes, KA.; Bennett, DE. and Coleman, DC. (1995): phenotypic and molecular cha-racterization of a novel species associated with oral candi-dosis in HIV-infected individuals. Microbiology 141: 507- 1521.
[56]
Vidigal, P G, Santos, S A, Fernandez M A, Bonfim P S 1, Martinez H V and Svidzinski T E (2011): Candiduria by Candida tropicalis evolves to fatal candidemia. Medical Case Studies 2: 22-25.
[57]
Vijaya D., Harsha T.R.and Nagaratnamma T.(2011):Candida Speciation Using Chrom Agar.Journal of Clinical and Diag-nostic Research. Vol-5(4): 755-757.
[58]
VincentJ. L., E. Anaissie, H. Bruining, W.Demajo, M. EI-Ebiary and J. Haber (1998): "Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under Intensive care", Intensive Care Med. 24: 206-216.
[59]
Wainer, S.;Cooper, PA.;Gouws, H. and Akierman, A. (1997): Prospective study of fluconazole therapy in systemic neonatal fungal infection. Pediatr Infect Dis J. 16:763-767.
[60]
Weinberger M., S. Sweet, L. Leibovici, S.D. Pitlik and Z. Samra (2003): "Correlation between candiduria and depart-mental antibiotic use", J. Hosp. Infect., 53, 183-186.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186